IRIS Accounts Production v24.3.0.553 09182591 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091825912023-08-31091825912024-08-31091825912023-09-012024-08-31091825912022-08-31091825912022-09-012023-08-31091825912023-08-3109182591ns15:EnglandWales2023-09-012024-08-3109182591ns14:PoundSterling2023-09-012024-08-3109182591ns10:Director12023-09-012024-08-3109182591ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3109182591ns10:SmallEntities2023-09-012024-08-3109182591ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3109182591ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3109182591ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3109182591ns10:FullAccounts2023-09-012024-08-3109182591ns10:Director22023-09-012024-08-3109182591ns10:CompanySecretary12023-09-012024-08-3109182591ns10:RegisteredOffice2023-09-012024-08-3109182591ns5:CurrentFinancialInstruments2024-08-3109182591ns5:CurrentFinancialInstruments2023-08-3109182591ns5:Non-currentFinancialInstruments2024-08-3109182591ns5:Non-currentFinancialInstruments2023-08-3109182591ns5:ShareCapital2024-08-3109182591ns5:ShareCapital2023-08-3109182591ns5:RetainedEarningsAccumulatedLosses2024-08-3109182591ns5:RetainedEarningsAccumulatedLosses2023-08-3109182591ns5:LeaseholdImprovements2023-08-3109182591ns5:PlantMachinery2023-08-3109182591ns5:FurnitureFittings2023-08-3109182591ns5:ComputerEquipment2023-08-3109182591ns5:LeaseholdImprovements2023-09-012024-08-3109182591ns5:PlantMachinery2023-09-012024-08-3109182591ns5:FurnitureFittings2023-09-012024-08-3109182591ns5:ComputerEquipment2023-09-012024-08-3109182591ns5:LeaseholdImprovements2024-08-3109182591ns5:PlantMachinery2024-08-3109182591ns5:FurnitureFittings2024-08-3109182591ns5:ComputerEquipment2024-08-3109182591ns5:LeaseholdImprovements2023-08-3109182591ns5:PlantMachinery2023-08-3109182591ns5:FurnitureFittings2023-08-3109182591ns5:ComputerEquipment2023-08-3109182591ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-08-3109182591ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-09-012024-08-3109182591ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-08-3109182591ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-08-3109182591ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3109182591ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-31
REGISTERED NUMBER: 09182591 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2024

FOR

ULTRACARDIAC LTD

ULTRACARDIAC LTD (REGISTERED NUMBER: 09182591)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ULTRACARDIAC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 AUGUST 2024







DIRECTORS: S C Gundry
Mrs S B G Gundry





SECRETARY:





REGISTERED OFFICE: c/o Batterbee Thompson & Co Ltd
Ocean Crescent
25 The Crescent
Plymouth
Devon
PL1 3AD





REGISTERED NUMBER: 09182591 (England and Wales)





ACCOUNTANTS: Batterbee Thompson & Co Ltd
Ocean Crescent
25 The Crescent
Plymouth
Devon
PL1 3AD

ULTRACARDIAC LTD (REGISTERED NUMBER: 09182591)

BALANCE SHEET
31 AUGUST 2024

2024 2023
as restated
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 373,778 296,263

CURRENT ASSETS
Debtors 5 85,258 63,947
Cash at bank 56,451 33,239
141,709 97,186
CREDITORS
Amounts falling due within one year 6 182,478 83,409
NET CURRENT (LIABILITIES)/ASSETS (40,769 ) 13,777
TOTAL ASSETS LESS CURRENT
LIABILITIES

333,009

310,040

CREDITORS
Amounts falling due after more than
one year

7

(101,229

)

(87,585

)

PROVISIONS FOR LIABILITIES (66,095 ) (66,095 )
NET ASSETS 165,685 156,360

ULTRACARDIAC LTD (REGISTERED NUMBER: 09182591)

BALANCE SHEET - continued
31 AUGUST 2024

2024 2023
as restated
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 165,485 156,160
SHAREHOLDERS' FUNDS 165,685 156,360

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 April 2025 and were signed on its behalf by:





Mrs S B G Gundry - Director


ULTRACARDIAC LTD (REGISTERED NUMBER: 09182591)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1. STATUTORY INFORMATION

ULTRACARDIAC LTD is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

ULTRACARDIAC LTD (REGISTERED NUMBER: 09182591)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2023 - 16 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 September 2023 35,425 514,898 77,617 23,018 650,958
Additions - 127,787 65,453 4,651 197,891
At 31 August 2024 35,425 642,685 143,070 27,669 848,849
DEPRECIATION
At 1 September 2023 3,544 303,508 33,465 14,178 354,695
Charge for year 708 83,742 31,070 4,856 120,376
At 31 August 2024 4,252 387,250 64,535 19,034 475,071
NET BOOK VALUE
At 31 August 2024 31,173 255,435 78,535 8,635 373,778
At 31 August 2023 31,881 211,390 44,152 8,840 296,263

ULTRACARDIAC LTD (REGISTERED NUMBER: 09182591)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£   
COST
At 1 September 2023 488,778
Additions 118,127
At 31 August 2024 606,905
DEPRECIATION
At 1 September 2023 283,923
Charge for year 79,044
At 31 August 2024 362,967
NET BOOK VALUE
At 31 August 2024 243,938
At 31 August 2023 204,855

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Trade debtors 85,258 63,947

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Bank loans and overdrafts 15,507 15,488
Hire purchase contracts 33,626 14,654
Trade creditors 68,141 -
Taxation and social security 58,398 47,574
Other creditors 6,806 5,693
182,478 83,409

ULTRACARDIAC LTD (REGISTERED NUMBER: 09182591)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
as restated
£    £   
Bank loans 11,828 27,355
Hire purchase contracts 89,401 60,230
101,229 87,585

Amounts falling due in more than five years:

Repayable by instalments
Hire purchase 89,401 60,230